[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2004, 30(2) 85-87 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
��������
Ƥ������
���������������
������
Ԭ����
�����
PubMed
Article by
Article by
Article by

Ƥ������������ָ�����о���չ

������, Ԭ����, �����

ɽ��ʡƤ�����Բ������о���, ���� 250022

ժҪ��

����ҽѧģʽ�ķ�չ,�����Ի�������������Ӱ��Խ��Խ�ܵ�����,����������Ϊҽѧ�����о�����Ҫ����֮һ.���������IJ���������һЩ��������ѹ㷺���ڸ����ٴ�,��Ϊ�Ը�Ԥ��ʩ��ҩ����Ч�ͼ���Ӱ�췽ʽ�ȵ�����.������Ƥ����ר������Ƥ������������ָ�����о����ŶȺ�Ч�ȵ����ۡ�Ӧ�ü�Ӧ���д��ڵ�����.

�ؼ����� ��������   Ƥ������  

Abstract:

Keywords:
�ո����� 2003-06-16 �޻�����  ����淢������  
DOI:
������Ŀ:

ͨѶ����:
���߼��:

�ο����ף�
[1] Finlay AY, Khan GK. Dermatology Life Quality Index(DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol,1994, 19(3):210-216.
[2] de Tiedra AG, Mercadal J, Badia X, et al. A method to select an instrument for measurement of HR-QOL for cross-cultural adaptation applied to dermatology. Pharmacoeconomics, 1998, 14(4):405-422.
[3] Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index(CDLQI):initial validation and practical use. Br J Dermatol,1995, 132(6):942-949.
[4] Loo WJ, Diba V, Chawla M, et al. Dermatology Life Quality Index:influence of an illustrated version. Br J Dermatol, 2003, 148(2):279284.
[5] Holme SA, Man I, Sharpe JL, et al. The Children's Dermatology Life Quality Index:validation of the cartoon version. Br J Dermatol,2003, 148(2):285-290.
[6] Badia X, Mascaro JM, Lozano R. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis:clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Research Group. Br J Dermatol, 1999,141(4):698-702.
[7] Mork C, Wahl A, Moum T. The Norwegian version of the dermatology life quality index:a study of validity and reliability in psoriatics. Acta Derm Venereol, 2002, 82(5):347-351.
[8] Parsad D, Pandhi R, Dogra S, et al. Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol, 2003, 148(2):373-374.
[9] Holme SA, Beattie PE, Fleming CJ. Cosmetic camouflage advice improves quality of life. Br J Dermatol, 2002, 147(5):946-949.
[10] Boehncke WH, Ochsendorf F, Paeslack I, et al. Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases.Eur J Dermatol, 2002, 12(6):577-580.
[11] Touw CR, Hakkaart-Van Roijen L, Verboom P, et al. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol, 2001, 144(5):967-972.
[12] Campanati A, Penna L, Guzzo T, et al. Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin:results of an open-label study. Clin Ther, 2003,25(1):298-308.
[13] Drake L, Prendergast M, Maher R, et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol, 2001, 44(1 Suppl):S65-72.
[14] Hahn HB, Melfi CA, Chuang TY,et al. Use of the Dermatology Life Quality Index(DLQI)in a midwestern US urban clinic. J Am Aead Dermatol, 2001, 45(1):44-48.
[15] Poon E, Seed PT, Greaves MW, et al. The extent and nature of disability in different urticarial conditions. Br J Dermatol, 1999, 140(4):667-671.
�������������
1���´�ɺ,������.���������ضԻ�������������Ӱ��[J]. ����Ƥ���Բ�ѧ��־, 2008,34(6): 379-381
2���̺鲨 ���� A.Y.Finlay.��м����������������������[J]. ����Ƥ���Բ�ѧ��־, 2009,35(5): 306-308
3�����ձ���, ��ѩ�����, �������У.Ƥ�������ߵ����������ⶨ:һ��ʵ����ָ��[J]. ����Ƥ���Բ�ѧ��־, 1998,24(6): 350-353
4���»�, л�츶.ϵͳ�Ժ���Ǵ����ߵ����������������о�[J]. ����Ƥ���Բ�ѧ��־, 2005,31(1): 18-20

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־